Mary A Richter, Legal Representative

Title: Mary A Richter - Innovator in Hematopoietic Cell Treatment

Introduction

Mary A Richter is a notable legal representative and inventor based in Vancouver, Canada. She has made significant contributions to the field of hematopoietic cell treatment through her innovative work. With one patent to her name, she has demonstrated her expertise and commitment to advancing medical science.

Latest Patents

Mary A Richter holds a patent for a CXCR4 antagonist treatment of hematopoietic cells. This invention outlines the use of CXCR4 antagonists to treat hematopoietic cells, such as progenitor or stem cells. The patent emphasizes the potential of these antagonists to promote cellular multiplication, self-renewal, proliferation, or expansion. Furthermore, it highlights their therapeutic applications in stimulating hematopoietic stem and progenitor cell multiplication and self-renewal.

Career Highlights

Throughout her career, Mary has worked with prominent organizations, including Chemokine Therapeutics Corporation and the University of British Columbia. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mary has collaborated with notable colleagues, including Christopher R Tudan and Ahmed Merzouk. These partnerships have further enriched her work and expanded the impact of her innovations.

Conclusion

Mary A Richter is a pioneering inventor whose work in hematopoietic cell treatment has the potential to transform medical therapies. Her dedication to innovation and collaboration underscores her significant role in advancing healthcare solutions.